For the longest time, there is question of what you make. The second question is what market do you go after. And so for the first five and half years of our company I only believed that the market was really number one. This preclinical and clinical pharma R&D. We didn't realize that there was...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
